Question 1

Am I eligible for this trial based on my recent biopsy results?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients clinical trial (NCT06476132). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients clinical trial (NCT06476132). Contact the study team or your healthcare provider for specific answers.

Question 3

How does Belumosudil compare to my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients clinical trial (NCT06476132). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my treatment and follow-up visits look like if I join this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients clinical trial (NCT06476132). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any side effects I should be aware of with Belumosudil?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients clinical trial (NCT06476132). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my participation in this trial affect my overall care and treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients clinical trial (NCT06476132). Contact the study team or your healthcare provider for specific answers.

What this study is about